Cutler Group LP Edwards Lifesciences Corp Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$61.71 - $77.76 $3,517 - $4,432	-57 Reduced 21.59%	207 $15,000
Q3 2023 Nov 07, 2023	SELL	$69.28 - $93.38 $6,928 - $9,338	-100 Reduced 27.47%	264 $18,000
Q2 2023 Jul 18, 2023	SELL	$81.41 - $94.33 $151,666 - $175,736	-1,863 Reduced 83.66%	364 $34,000
Q1 2023 May 01, 2023	SELL	$74.26 - $84.51 $405,979 - $462,016	-5,467 Reduced 71.06%	2,227 $184,000
Q4 2022 Feb 07, 2023	BUY	$68.3 - $87.44 $395,457 - $506,277	5,790 Added 304.1%	7,694 $574,000
Q3 2022 Oct 25, 2022	BUY	$82.37 - $107.29 $40,855 - $53,215	496 Added 35.23%	1,904 $157,000
Q2 2022 Aug 04, 2022	SELL	$86.5 - $128.27 $341,588 - $506,538	-3,949 Reduced 73.72%	1,408 $133,000
Q1 2022 Apr 14, 2022	BUY	$101.96 - $128.34 $514,184 - $647,218	5,043 Added 1606.05%	5,357 $630,000
Q4 2017 Jan 17, 2018	SELL	$33.79 - $39.39 $141,411 - $164,847	-4,185 Reduced 93.02%	314 $35,000
Q3 2017 Oct 17, 2017	BUY	$36.29 - $38.83 $163,268 - $174,696	4,499	4,499 $491,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.